-
EP4351613
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4351613
| EP4351613 - METHODS, COMPOSITIONS AND USES FOR TARGETING SEMA7A IN THE DIAGNOSIS AND TREATMENT OF HEALTH CONDITIONS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.03.2024 Database last updated on 11.04.2026 | |
| Former | The international publication has been made Status updated on 09.12.2022 | Most recent event Tooltip | 09.12.2025 | Amendment by applicant | Applicant(s) | For all designated states THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 1800 Grant Street, 8th Floor Denver, CO 80203 / US | [2024/16] | Inventor(s) | 01 /
LYONS, Traci R. Denver, Colorado 80045 / US | [2024/16] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2024/16] | Application number, filing date | 22816784.7 | 01.06.2022 | [2024/16] | WO2022US31800 | Priority number, date | US202163195572P | 01.06.2021 Original published format: US 202163195572 P | US202163234594P | 18.08.2021 Original published format: US 202163234594 P | [2024/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022256420 | Date: | 08.12.2022 | Language: | EN | [2022/49] | Type: | A1 Application with search report | No.: | EP4351613 | Date: | 17.04.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.12.2022 takes the place of the publication of the European patent application. | [2024/16] | Search report(s) | International search report - published on: | US | 08.12.2022 | (Supplementary) European search report - dispatched on: | EP | 10.06.2025 | Classification | IPC: | A61K38/00, C07K14/47 | [2024/16] | CPC: |
C07K14/4703 (EP,US);
C07K16/2896 (EP,US);
A61P35/00 (EP,US);
C07K14/4705 (EP);
A61K2039/505 (EP,US);
A61K38/00 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/16] | Title | German: | VERFAHREN, ZUSAMMENSETZUNGEN UND VERWENDUNGEN ZUM TARGETING VON SEMA7A BEI DER DIAGNOSE UND BEHANDLUNG VON GESUNDHEITSZUSTÄNDEN | [2024/16] | English: | METHODS, COMPOSITIONS AND USES FOR TARGETING SEMA7A IN THE DIAGNOSIS AND TREATMENT OF HEALTH CONDITIONS | [2024/16] | French: | PROCÉDÉS, COMPOSITIONS ET UTILISATIONS POUR LE CIBLAGE DE SEMA7A POUR LE DIAGNOSTIC ET LE TRAITEMENT D'ÉTATS DE SANTÉ | [2024/16] | Entry into regional phase | 18.12.2023 | National basic fee paid | 18.12.2023 | Search fee paid | 18.12.2023 | Designation fee(s) paid | 18.12.2023 | Examination fee paid | Examination procedure | 18.12.2023 | Examination requested [2024/16] | 08.12.2025 | Amendment by applicant (claims and/or description) | 08.12.2025 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 27.06.2024 | Renewal fee patent year 03 | 28.06.2025 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] US2021009712 (ELIAS JACK A et al.) [X] 1-12,14 * the whole document * | [X] US2010104570 (ELIAS JACK A et al.) [X] 1-12,14 * the whole document * | [X] US6225285 (LUO YULING et al.) [X] 1-12,14 * the whole document * | [X] US2015111781 (GARCIA-AREAS RAMON et al.) [X] 1-12,14 * the whole document * | [X] BORGES VIRGINIA F. ET AL: "Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer", NPJ BREAST CANCER, vol. 6, no. 1, 19 October 2020 (2020-10-19), XP093075110, DOI: 10.1038/s41523-020-00198-1 [X] 1-12,14 * the whole document * DOI: http://dx.doi.org/10.1038/s41523-020-00198-1 | [X] TARULLO SARAH E ET AL: "Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival", ONCOGENE, NATURE PUBLISHING GROUP UK, LONDON, vol. 39, no. 13, 4 February 2020 (2020-02-04), pages 2772 - 2785, XP037075605, ISSN: 0950-9232, [retrieved on 20200204], DOI: 10.1038/S41388-020-1192-9 [X] 1-12,14 * the whole document * DOI: http://dx.doi.org/10.1038/s41388-020-1192-9 | [X] GLYNIS A SCOTT ET AL: "Semaphorin 7a Promotes Spreading and Dendricity in Human Melanocytes through beta1-Integrins", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 128, 2 August 2007 (2007-08-02), pages 151 - 161, XP008141230, ISSN: 0022-202X, [retrieved on 20070802], DOI: 10.1038/SJ.JID.5700974 [X] 1-12,14 * the whole document * DOI: http://dx.doi.org/10.1038/sj.jid.5700974 | [A] SONG YAO ET AL: "The involvement of semaphorin 7A in tumorigenic and immunoinflammatory regulation", JOURNAL OF CELLULAR PHYSIOLOGY, vol. 236, no. 9, 21 February 2021 (2021-02-21), US, pages 6235 - 6248, XP093075424, ISSN: 0021-9541, DOI: 10.1002/jcp.30340 [A] 1-12,14 * the whole document * DOI: http://dx.doi.org/10.1002/jcp.30340 | International search | [X] US2002106722 (MICHALOVICH DAVID et al.) [X] 1-6, 17-19 * ; 0010, 0011, 0012, 0039, 0051, 0062, 0087, 0090 * |